Skip to main content
. 2023 Sep 8;2023(9):CD001888. doi: 10.1002/14651858.CD001888.pub5

7. Overview of included studies (PICO) ‐ Obstetrics.

Study details Population (surgery type) CS detail Intervention detail Control detail Outcomes reported (time point)
Khan 2017 (SALVO)
RCT 
Registration: Prospective 
Country: UK 
N = 1356 Obstetrics (Caesarean section) Timing of collection: intraoperative 
Washing: washed 
Transfusion threshold: No threshold 
System: Varied according to centre Cell Salvage
N = 669 Control
N = 687
  • Transfusions (intraoperative or to discharge)

  • Volume (intraoperative or to discharge)

  • Hospital LOS (NA)

ANH: acute normovolemic haemodilution; AT: autotransfusion; CABG: cardiopulmonary bypass graft; CS: cell salvage; CVA: cerebrovascular accident; DVT: deep vein thrombosis; Hb: haemoglobin; Hct: haematocrit; LOS: hospital length of stay; MACE: major adverse cardiovascular events; MI: myocardial infarction; N: planned recruitment (as reported by the study); NA: not analysable; NR: not reported; PE: pulmonary embolism; PJI: prosthetic joint infection; RAP: retrograde autologous prime; RCT: randomised controlled trial; VTE: venous thromboembolism

"Registration: N/A" means 'not applicable' as the study was published before 2010
"Volume" refers to mean transfusion volume
"Transfusions" refers to number of people receiving an allogeneic transfusion